Document:

STOCK
        TRANSFER AGREEMENT

       

      THIS
        STOCK TRANSFER AGREEMENT
        (this
“Agreement”)
        is
        made and entered into as of the 20th day of February, 2007, by and among
        Celsia
        Technologies, Inc., a Nevada corporation (the “Company”),
        Hakan
        Wretsell (“Wretsell”),
        Michael Karpheden (“Karpheden”),
        Axiom
        Capital Management, Inc. (the “Agent”)
        and
        each other person or entity listed as a Purchaser on Schedule
        1
        attached
        to this Agreement, as such Schedule I shall be revised from time to time
        (the
“Purchasers”).
        Wretsell and Karpheden are sometimes collectively referred to herein as the
        “Executive
        Officers”
and
        individually as an “Executive
        Officer.”
        

       

      Recitals

       

      WHEREAS,
        the
        Company desires to sell and issue Secured Convertible Promissory Notes in
        the
        aggregate principal amount of not less than Two Hundred Fifty Thousand Dollars
        ($250,000) and not more than One Million Dollars ($1,000,000) (individually,
        a
“Convertible
        Note,”
and
        collectively, the “Convertible
        Notes”);

       

      WHEREAS,
        Wretsell
        and Karpheden are the duly appointed Chief Executive Officer and Chief Financial
        Officer of the Company, respectively, and own certain shares of common stock,
        par value $0.001 per share, of the Company (the “Common
        Stock”),
        and
        as such have a material interest in the consummation of the sale of the
        Convertible Notes;

       

      WHEREAS,
        the
        Convertible Notes will be sold in multiple closings to the Purchasers pursuant
        to Securities Purchase Agreements between the Company and each Purchaser
        (each a
“Purchase
        Agreement”
and
        collectively the “Purchase
        Agreements”);
        and

       

      WHEREAS,
        the
        Purchasers have required as a condition to purchasing the Convertible Notes,
        and
        as an inducement for the Purchasers to purchase the Convertible Notes, the
        Executive Officers have agreed, to transfer certain shares of Common Stock
        owned
        by the Executive Officers to the Purchasers in the event that a Qualified
        Debenture Financing (as defined in the Convertible Notes) does not occur
        on or
        before June 20, 2007 (the “Trigger
        Date”),
        all
        in accordance with and subject to the terms of this Agreement.

       

      NOW,
        THEREFORE,
        in
        consideration of the foregoing and the mutual covenants and agreements contained
        herein, the parties hereto, intending to be legally bound, agree as
        follows:

       

      1. Incorporation
        of Recitals.
        The
        foregoing Recitals are hereby incorporated herein in their entirety by this
        reference.

       

      2. Definitions.
        Capitalized terms used herein and not otherwise defined shall have the meanings
        set forth in the Convertible Notes. 

       

      3. Transfer
        of Securities.
        As
        further described herein and in accordance with the terms and subject to
        the
        conditions of this Agreement, in the event a Qualified Debenture Financing
        has
        not occurred on or before the Trigger Date, Wretsell agrees to transfer 462,588
        shares of Common Stock owned by him (the “Wretsell
        Stock”)
        and
        Karpheden agrees to transfer 271,677 shares of Common Stock owned by him
        (the
“Karpheden
        Stock,”
and,
        collectively with the Wretsell Stock, the “Executive
        Officer Stock”)
        to the
        Purchasers, free and clear of any liens or encumbrances (other than restrictive
        legends), pro rata among the Purchasers in accordance with the principal
        amounts
        of the Convertible Notes purchased by the Purchasers pursuant to the Purchase
        Agreements.

       

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      (a)  As
        further assurance of the performance of the Executive Officer’s obligations
        hereunder, the Executive Officers hereby assign, transfer and grant the
        Executive Officer Stock to the Agent to hold for the benefit of the Purchasers.
        All certificates representing the Executive Officer Stock have been delivered
        to
        and are being held by or on behalf of Agent pursuant hereto. All certificates
        representing Executive Officer Stock shall be in suitable form for transfer
        by
        delivery or shall be accompanied by duly executed instruments of transfer
        or
        assignment in blank, with signature(s) thereon guaranteed by a financial
        institution that is a member of a Stock Transfer Association approved medallion
        program such as STAMP, SEND or MSP, or, in the case of Wretsell, accompanied
        by
        a letter from the company guaranteeing Wretsell’s signature, and otherwise in
        form and substance satisfactory to Agent and subject to any applicable law
        or
        regulations. Notwithstanding the above, in the event the Company issues less
        than $1 million in aggregate principal amount of Convertible Notes, a number
        of
        shares of Executive Officer Stock equal to (i) the percentage obtained by
        dividing (A) the difference between $1 million and the aggregate principal
        amount of Convertible Notes issued by the Company by (B) $1 million, multiplied
        by (ii) the number of shares of Executive Officer Stock (the “Excess
        Shares”)
        shall
        be returned to the Executives, pro rata between Wretsell and Karpheden in
        accordance with the number of shares of Wretsell Stock and Karpheden Stock.
        Until such time as the Executive Officer Stock is transferred to the Purchasers
        in accordance with the terms hereof, the Executive Officer shall retain all
        voting rights relating to the Executive Officer Stock.

       

      (b) In
        the
        event a Qualified Debenture Financing shall not have occurred on or before
        the
        Trigger Date, the Agent shall endorse, assign or otherwise transfer the
        Executive Officer Stock to the Purchasers pro rata in accordance with the
        principal amounts of the Convertible Notes purchased by the Purchasers pursuant
        to the Purchase Agreements. In connection therewith, the Agent shall have
        the
        right at any time to exchange certificates representing or evidencing the
        Executive Officer Stock for certificates of smaller or larger
        denominations.

       

      (c)  Upon
        the
        occurrence of a Qualified Debenture Financing on or before the Trigger Date
        or
        the earlier termination of this Agreement (other than a termination resulting
        from the transfer of the Executive Officer Stock to the Purchasers pursuant
        to
        this Agreement), the Agent shall return, assign or otherwise transfer the
        Executive Officer Stock to the Executive Officers.

       

      4. Representations
        and Warranties.
        Wretsell hereby represents and warrants that he
        is the
        sole legal and beneficial owner of the Wretsell Stock, and Karpheden hereby
        represents and warrants that he is the sole legal and beneficial owner of
        the
        Karpheden Stock, in each case free and clear of any liens or
        encumbrances.

       

      5. Covenants
        and Agreements.
        The
        Company hereby acknowledges and agrees to the existence and terms of this
        Agreement. In the event that the Company effectuates a stock split with respect
        to the Common Stock, or makes a distribution of Common Stock to all holders
        of
        Common Stock, the additional shares of Common Stock issued with respect to
        the
        Executive Officer Stock shall constitute additional Executive Officer Stock,
        and
        the Executive Officers shall take all steps necessary to deliver any stock
        certificates relating to such additional Executive Officer Stock to the Agent
        in
        accordance with the terms hereof. In the event the Company distributes any
        of
        its assets to all the holders of Common Stock, such assets distributed with
        respect to the Executive Officer Stock shall be held by Agent and shall be
        transferred together with the Executive Officer Stock in accordance with
        the
        terms of this Agreement. The parties hereto hereby agree to execute,
        acknowledge, deliver and cause to be duly filed all further instruments and
        documents and take all such actions as a party hereto may from time to time
        reasonably request for effectuating the terms of this Agreement and the rights
        created hereby. 

       

      
        
          
          

        

        
          2

          
            

          

        

        
          
          

        

      

       

      6. Designation
        of Agent; Indemnity.
        

       

      (a)  Until
        the
        termination of this Agreement, the Purchasers hereby irrevocably designate
        Axiom
        (and its successors and assigns) as their agent and Axiom hereby accepts
        such
        designation, in order to execute any and all instruments or other documents
        on
        behalf of the Purchasers and to do any and all other acts or things on behalf
        of
        the Purchasers that Axiom (or its successors or assigns) in its sole discretion
        deems necessary or advisable or that may be required pursuant to this Agreement
        or otherwise, to exercise Purchasers’ rights and remedies under this Agreement.
        None of the Purchasers may take any action or exercise any rights under this
        Agreement except through Axiom as their agent. Notwithstanding anything to
        the
        contrary set forth herein, this Agreement may be waived, modified, amended,
        terminated or discharged only in accordance with Section 7
        hereof.

       

      (b) Axiom,
        as
        agent, shall have no duties or responsibilities whatsoever with respect to
        the
        Executive Officer Stock except as are specifically set forth herein. Axiom,
        in
        its capacity as agent for the Purchasers, shall neither be responsible for
        or
        under, nor chargeable with knowledge of the terms and conditions of, any
        other
        agreement, instrument or document in connection herewith. Axiom may conclusively
        rely upon, and shall be fully protected from all liability, loss, cost, damage
        or expense in acting or omitting to act pursuant to any written notice,
        instrument, request, consent, certificate, document, letter, telegram, opinion,
        order, resolution or other writing hereunder without being required to determine
        the authenticity of such document, the correctness of any fact stated therein,
        the propriety of the service thereof or the capacity, identity or authority
        of
        any party purporting to sign or deliver such document. Axiom shall have no
        responsibility for the contents of any such writing contemplated herein and
        may
        rely without any liability upon the contents thereof.

       

      (c)  Axiom,
        in
        its capacity as agent for the Purchasers, shall not be liable for any action
        taken or omitted by it in good faith and reasonably believed by it to be
        authorized hereby or with the rights or powers conferred upon it hereunder,
        nor
        for action taken or omitted by it in good faith, and in accordance with advice
        of counsel (which counsel may be of Axiom’s own choosing), and shall not be
        liable for any mistake of fact or error of judgment or for any acts or omissions
        of any kind except for its own willful misconduct or gross
        negligence.

       

      (d) Each
        of
        the Purchasers (each, an “Indemnifying
        Parties”)
        agrees
        to indemnify Axiom, in its capacity as agent for the Purchasers, and its
        employees, directors, officers and agents and hold each harmless against
        any and
        all liabilities incurred by it hereunder as a consequence of such party's
        action, and each Indemnifying Party agrees to indemnify Axiom, in its capacity
        as agent for the Purchasers, and hold it harmless against any claims, costs,
        payments, and expenses (including the reasonable fees and expenses of counsel)
        and all liabilities incurred by it in connection with the performance of
        its
        duties hereunder, except in the case for claims, costs, payments, and expenses
        (including the reasonable fees and expenses of counsel) and liabilities incurred
        by Axiom resulting from its own willful misconduct or gross
        negligence.

       

      
        
          
          

        

        
          3

          
            

          

        

        
          
          

        

      

       

      7. Miscellaneous.
        This
        Agreement can be waived, modified, amended, terminated or discharged only
        explicitly in a writing signed by the Company, Executive Officers and the
        Required Majority; provided, however, that (i) Schedule
        1
        hereto
        shall be revised by the Company from time to time to reflect additional
        Purchasers as parties to this Agreement without the written consent of any
        other
        party to this Agreement and (ii) unless earlier terminated by the parties
        in
        accordance with this Section 7, this Agreement shall terminate upon the transfer
        of the Executive Officer Stock pursuant to Section 3(b) or 3(c) hereof. A
        waiver
        shall be effective only in the specific instance and for the specific purpose
        given. Mere delay or failure to act shall not preclude the exercise or
        enforcement of any rights or remedies. This Agreement shall be binding upon
        and
        inure to the benefit of the parties hereto and their respective participants,
        successors, and permitted assigns and shall take effect when signed by Company,
        Agent, Executive Officers and a Purchaser. Purchasers’ rights hereunder may not
        be transferred or assigned to any third party without the prior written consent
        of the Executive Officers. This Agreement shall be governed by the internal
        law
        of the State of New York without regard to conflicts of law provisions. Any
        legal action or proceeding with respect to this Agreement shall be brought
        exclusively in the courts of the State of New York or of the United States
        of
        America sitting in New York County, and, by execution and delivery of this
        Agreement, the parties hereto hereby accept for itself and in respect of
        its
        property, generally and unconditionally, the jurisdiction of the aforesaid
        courts. If any provision or application of this Agreement is held unlawful
        or
        unenforceable in any respect, such illegality or unenforceability shall not
        affect other provisions or applications which can be given effect and this
        Agreement shall be construed as if the unlawful or unenforceable provision
        or
        application had never been contained herein or prescribed hereby.

       

      8. Waiver
        of Jury Trial:
        EACH OF THE PARTIES HERETO HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY
        WAIVES THE RIGHT COMPANY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY
        LITIGATION BASED HEREON OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS
        AGREEMENT AND ANY AGREEMENT CONTEMPLATED TO BE EXECUTED IN CONJUNCTION HEREWITH,
        OR ANY COURSE OF CONDUCT, COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR
        WRITTEN) OR ACTIONS OF EITHER PARTY. THIS PROVISION IS A MATERIAL INDUCEMENT
        FOR
        SECURED PARTY ENTERING INTO THIS AGREEMENT.

       

      9. Notices.
        Any
        notices, consents, waivers, or other communications required or permitted
        to be
        given under the terms of this Agreement (“Notices”)
        shall
        be given in accordance with Section 5.7 of the Purchase Agreements; provided,
        however, that all Notices to Wretsell or Karpheden shall be sent to the
        addresses set forth on the signature page hereto with a copy to the Company
        and
        Agent shall be copied on all notices at Axiom Capital Management, Inc., 780
        Third Avenue, 43rd Floor, New York, New York 10017, attn: Marcelo Martins,
        facsimile (212) 251-3888.

      
        
          
          

        

        
          4

          
            

          

        

        
          
          

        

      

      IN
        WITNESS WHEREOF,
        the
        parties have duly executed and delivered this Stock Transfer Agreement as
        of the
        date and year first written above.

       

      
        	HAKAN
                WRETSELL:	 	 	
                AGENT:

                 

                AXIOM
                  CAPITAL MANAGEMENT, INC.

              
	 	 	 	 	 
	 	 	 	 	 
	/s/ Hakan
                Wretsell 	 	 	By: 	/s/ Mark
                D.
                Martino
	
                
Hakan
                Wretsell	 	 	 	
                

                Name:
                  Mark D. Martino

                Title:
                  President

              
	
                
                  Address:
                    ___________________________

                          
                    ______________________

                  ______________________

                   

                  Facsimile: 
                    ______________________

                

              	 	 	 	 

      

      
         

        
          	MICHAEL
                  KARPHEDEN:	 	 	
                  
                    COMPANY:

                     

                    CELSIA
                      TECHNOLOGIES, INC. 

                  

                
	 	 	 	 	 
	 	 	 	 	 
	/s/ Michael
                  Karpheden 	 	 	By: 	/s/ Michael
                  Karpheden
	
                  
Michael
                  Karpheden	 	 	 	
                  

                  
                    Name:
                      Michael Karpheden

                    Title:
                      Chief Financial Officer

                  

                
	
                  Address:
                    ________________________

                          
                    ____________________

                  ______________________

                   

                  Facsimile: 
                    ______________________

                	 	 	 	 

        

        

          
            
              
              

            

            
              5

              
                

              

            

             

          

        

         

      

      COUNTERPART
        SIGNATURE PAGE

      TO
        STOCK
        TRANSFER AGREEMENT

      DATED
        FEBRUARY 20, 2007

       

      The
        undersigned hereby executes and delivers the Stock Transfer Agreement to
        which
        this Signature Page is attached, which, together with all counterparts of
        the
        Stock Transfer Agreement and Signature Pages of the Company, Agent, Executive
        Officers and other “Purchasers” under the Stock Transfer Agreement, shall
        constitute one and the same document in accordance with the terms of the
        Stock
        Transfer Agreement.

       

      
        	 	
                 

                PURCHASER:___________________________*

                 

              	 	 	 
	By: 	 	 	 	
              
	 	
                

                Name:_______________________________

                Title:________________________________

              	 	 	
              

      

       

      *
        Executed by each Purchaser 

       

      
        
          
          

        

        
          6Exhibit
      10.1 

     

    February
      28, 2007

    

    Mark
      R.
      Stier

    50
      Ethelbert Place, 

    Ridgewood,
      NJ 07450

    

    

    Dear
      Mark:

    

    I
      am
      pleased to present this offer letter of employment with Keryx
      Biopharmaceuticals, Inc. (the “Corporation”) pursuant to which you will become
      the Vice President and Chief Accounting Officer (the “CAO”) under the terms
      and conditions described below:

    

    
      	 	
              1.

            	
              You
                will report directly to the Chief Financial Officer of the Corporation
                (the “CFO”) and you will have primary responsibility for managing all
                activities of general accounting functions, with overall responsibility
                for SEC reporting, accounting, tax, and external audit compliance
                functions. You will also be responsible for overseeing the financial
                and
                accounting system controls and processes to ensure timely financial
                reporting that adheres to Generally Accepted Accounting Principles
                ("GAAP"), SEC reporting, Sarbanes Oxley compliance and local statutory
                reporting requirements. You agree to devote your entire business
                time and
                attention to the performance of your employment duties to the Corporation
                except as otherwise agreed in advance in writing by the
                Corporation.

            

    

     

    
      	 	
              2.

            	
              You
                will receive a base salary of $275,000 per annum. In addition to
                the base
                salary, you will be eligible to receive an annual performance-based
                bonus
                of up to 50% of your annual base salary, payable only if you are
                employed
                by the Corporation at the time such bonus is paid. The annual
                performance-based bonus will be based upon annual target performance
                objectives to be agreed upon by you and the CFO and CEO on or before
                December 15 immediately preceding the fiscal year for which the
                performance bonus shall be applicable. For 2007, you shall be eligible
                for
                the full potential bonus.

            

    

     

    
      	 	
              3.

            	
              You
                will also receive an initial option grant of 100,000 options vesting
                over
                four years, with the first one-quarter vesting on the first anniversary
                of
                the Date of employment and thereafter the options shall vest in equal
                quarterly installments through the fourth anniversary of the date
                of
                employment. Your options will be granted pursuant to an executive
                incentive plan and shall be issued on the effective date of your
                employment with the Corporation, or as soon as possible thereafter,
                and
                your options will be priced at the fair market value of the common
                stock
                on the date of grant. In addition, on an annual basis you shall be
                eligible for additional stock option grants of up to 25% of your
                initial
                grant (e.g. up to 25,000) based on the achievement of corporate level
                G&Os, which will form the basis of your bonus
                calculation.

            

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    
      	 	
              4.

            	
              For
                calendar year beginning January 1, 2007, you shall be entitled to
                fifteen
                (15) business days of leave, thereafter you shall be entitled to
                twenty
                (20) business days of leave per calendar year. Any leave not taken
                in a
                particular calendar year will be forfeited and not carried forward
                into
                the next calendar year. In addition, you shall be entitled to those
                holidays set forth, from time to time, by the Company.
                

            

    

     

    
      	 	
              5.

            	
              Your
                start date shall be March 19, 2006.

            

    

     

    
      	 	
              6.

            	
              Either
                party may terminate your employment with the Corporation without
                cause and
                without Good Reason at any time upon ninety (90) days’ notice, provided,
                however that if such termination occurs without cause or good reason
                in
                the first twelve (12) months following the Effective Date, the Corporation
                shall pay your full salary and benefits (excluding bonus) until the
                first
                anniversary of the Effective Date. The Corporation shall have the
                right,
                in its sole discretion, to require you to continue working for the
                Corporation during the notice period. If you are terminated by the
                Corporation in the event of a change in control, all your options
                will
                become immediately vested and they shall remain exercisable until
                the
                earlier of: (i) 2 years following such termination and (ii) for the
                full
                term of such Options. If you are terminated in connection with a
                “qualified” change in control, then you shall also receive your base
                salary for one year (paid in a lump sum at the time of termination).
                A
                qualified change in control shall mean a “change
                in control”,
                which places a value on the Corporation of in excess of $1.5 billion.
                

            

    

     

    
      	 	
              7.

            	
              The
                Corporation shall make available to you and your dependents such
                health
                benefits as the Corporation makes generally available to its other
                employees. The Corporation shall reimburse you for all reasonable
                business
                expenses incurred by you, including, without limitation, professional
                fees
                associated with maintaining your professional accounting credentials
                (e.g.
                registration fees, CPE costs, AICPA
                membership)

            

    

     

    
      	 	
              8.

            	
              Your
                employment will be governed by the Corporation’s Personnel Policies and
                Procedures handbook and ADP TotalSource’s Basic Employment Policies and
                such other corporate policies as are from time to time implemented
                including without limitations the Corporation’s insider trading policies
                and code of conduct and ethics. In addition, as a condition to your
                employment, you will be required to execute the Corporation’s standard
                Proprietary Information and Inventions
                Agreement.

            

    

     

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    Mark,
      I
      very much look forward to working together. Please sign one copy and return
      to
      me. Keep the other copy for your records.

    

    
    

    
      	 	
              Very
                truly yours,

              

              /s/
                Michael S. Weiss

              

              Michael
                S. Weiss

              Chairman
                & Chief Executive Officer

            

    

    

    

    

    AGREED
      AND ACCEPTED:

    

    

    /s/
      Mark R.
      Stier                                  

    February
      28, 2007   

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    Addendum
      to Offer Letter of Employment

    

    

    March
      23,
      2007

    

    Mark
      R.
      Stier

    50
      Ethelbert Place, 

    Ridgewood,
      NJ 07450

    

    Dear
      Mark:

    

    This
      addendum to your offer letter of employment between you and Keryx
      Biopharmaceuticals, Inc. (the “Corporation”), dated February 28, 2007, hereby
      confirms that the Compensation Committee of the Corporation’s Board of Directors
      (the “Committee”), appointed you as the Corporation’s Chief Accounting Officer
      effective today, March 23, 2007 (the “Effective Date”). Accordingly, the
      Committee approved your initial option grant of 100,000 options, at an exercise
      price of $11.11, which represents the fair market value of the Corporation’s
      common stock as of the date of grant, vesting over four years, with the first
      one-quarter vesting on the first anniversary of the Effective Date, pursuant
      to
      an inducement plan, a copy of which is attached. 

    

    In
      addition, pursuant to your offer letter of employment, the following terms,
      which are applicable only for the first twelve months of your employment, are
      defined as follows:

    

    Cause

    “Cause”
      for termination by the Company shall mean: (a) a material breach of your
      obligations pursuant to your offer letter dated February 28, 2007, or this
      addendum thereto; (b) a material breach by you of any other provision of this
      offer letter of employment, which is not cured by you within fifteen (15) days
      after receiving notice thereof from the Corporation containing a description
      of
      the breach or breaches alleged to have occurred; (c) the habitual neglect or
      gross failure by you to adequately perform the duties of your position; (d)
      any
      act of moral turpitude or criminal action connected to your employment with
      the
      Corporation or your place of employment; or (e) your repetitive refusal to
      comply with or your violation of lawful instructions of the Chief Executive
      Officer, Chief Financial Officer or the Board of Directors, unless cured within
      fifteen (15) days after receiving notice thereof.

     

    

    Good
      Reason

    “Good
      Reason” for you to resign shall mean: (A) a material diminution in your duties,
      or the assignment to you of duties materially inconsistent with your authority,
      responsibilities and reporting requirements as set forth in your offer letter
      of
      employment; or (B) a material breach by the Corporation of its obligations
      to
      you under the terms of this offer letter of employment.
      Anything hereinabove to the contrary notwithstanding, in the event you elect
      to
      terminate your employment for Good Reason, you agree to provide the Corporation
      with thirty (30) days prior written notice of your intent to leave the
      Corporation and the alleged condition or breach constituting Good Reason. In
      the
      event the Corporation cures such condition or breach within thirty (30) days
      following receipt of such notice, any such termination based on such alleged
      breach or condition shall not be considered a termination by you for Good
      Reason.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    Mark,
      I
      very much look forward to working together. Please sign one copy and return
      to
      me. Keep the other copy for your records.

    

    

    
      	 	
              Very
                truly yours,

              

              /s/
                Michael S. Weiss

              

              Michael
                S. Weiss

              Chairman
                & Chief Executive Officer

            

    

    

    

    

    AGREED
      AND ACCEPTED:

    

    

    /s/
      Mark R.
      Stier                       

    March
      23,
      2007

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00122-of-00352.parquet"}]]